RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S. ...Middle East

TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced its plans to expand the Company's global Phase 2/3 study of opaganib[1] in patients with severe...

Hence then, the article about redhill biopharma announces planned expansion of opaganib global phase 2 3 covid 19 study to the u s was published today ( Tuesday 23/02/2021 - 03:17 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S. )

Also on site :

• Drone footage shows aftermath of Iranian missile attack in Tel Aviv
• Drugs, weapons and cash seized in Sandwell police crackdown
• War in Iran Is Disrupting Air Travel, Hitting Middle East Hardest